GLOW is a pre-blended research material supplying three compounds in a single lyophilized vial: GHK-Cu, BPC-157, and TB-500, 70mg total. It is one vial, not a multi-vial kit, and it is supplied as powder.
What GLOW refers to
GLOW is shorthand researchers use for a three-compound grouping that appears in repair and recovery study designs. It is not a consumer bundle and not a usage plan. The interest comes from the literature, where the proposed mechanisms of each compound are described as touching different but related parts of the repair picture.
The three compounds
GHK-Cu (copper tripeptide) is a naturally occurring copper-binding tripeptide studied in research models for its role in collagen synthesis and extracellular matrix remodeling. The copper-binding feature is central to much of that work.
BPC-157 is a synthetic peptide fragment investigated in research models in the context of tissue repair, angiogenesis, and connective-tissue pathways. Most published work sits in preclinical animal models examining repair-pathway activity rather than any clinical endpoint.
TB-500 is a synthetic fragment related to thymosin beta-4, studied in research models for its association with cell migration and actin regulation. The actin-binding work is the most distinctive part of that literature and is often cited as the reason it appears alongside BPC-157.
Why these three are grouped
Laid next to each other, the three describe different layers of the same broad repair question, which is why research-model co-administration designs sometimes include all three. BPC-157 and TB-500 in particular have been examined together in contexts exploring overlapping repair-pathway activity. The addition of GHK-Cu extends the matrix and collagen-related angle.
This is a description of how compounds are grouped in study designs, not a recommendation for any in-vivo use. The literature describes proposed and studied associations, not established outcomes.
Supplied as a single pre-blended vial
GLOW ships as one lyophilized vial containing all three compounds. Etched does not sell multi-vial kits and does not supply reconstituted material. Powder only.
Specifications
- Contents: GHK-Cu 50mg + BPC-157 10mg + TB-500 10mg, 70mg total, pre-blended in one vial
- GHK-Cu: C14H24N6O4·Cu, 403.91 g/mol (copper complex), sequence Gly-His-Lys
- BPC-157: C62H98N16O22, 1419.54 g/mol, sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
- TB-500: synthetic fragment related to thymosin beta-4
- Form: lyophilized powder
- Storage: -20°C lyophilized
FOR IN VITRO RESEARCH USE ONLY. NOT FOR HUMAN CONSUMPTION, INGESTION, OR ANY IN VIVO USE.
Further reading
- GLOW: a research overview of GHK-Cu, BPC-157, and TB-500
- BPC-157 and TB-500: research overview of the two-compound blend


